Us CD137 Protein Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
CD137 Protein Market was valued at USD 0.75 Billion in 2022 and is projected to reach USD 1.50 Billion by 2030, growing at a CAGR of 9% from 2024 to 2030.
The US CD137 protein market is rapidly gaining traction, driven by its pivotal role in immunotherapy. CD137, also known as 4-1BB, is a cell surface receptor primarily expressed on T cells, natural killer cells, and antigen-presenting cells. Its significance in immune regulation has made it a target for cancer immunotherapies. In particular, CD137 activation boosts the immune system’s ability to target and destroy cancer cells, making it a cornerstone in the development of next-generation cancer treatments.
The market for CD137-related therapies has seen a surge in the US, owing to increasing investment in immuno-oncology. CD137 agonists, including monoclonal antibodies and recombinant proteins, are being tested in various clinical trials for cancers such as melanoma, non-small cell lung cancer, and ovarian cancer. The potential for these therapies to revolutionize cancer treatment has caught the attention of both pharmaceutical companies and researchers, pushing the market's growth.
In the US, CD137-based therapies are being developed by several pharmaceutical giants, such as Merck & Co. and Bristol-Myers Squibb, both of whom are at the forefront of immuno-oncology. Furthermore, the rapid advancements in gene editing and the increasing use of immunotherapies have paved the way for more effective treatments. With the push towards personalized medicine, CD137-targeted therapies are gaining popularity due to their ability to enhance tumor-specific immune responses.
Market growth is also fueled by ongoing investments in research, particularly in the discovery of combination therapies. By combining CD137 agonists with other checkpoint inhibitors or chemotherapy agents, researchers hope to overcome resistance and improve treatment outcomes. This trend is expected to continue as clinical trials yield promising results.
While the US CD137 protein market shows tremendous promise, challenges remain. These include high treatment costs and the need for more extensive long-term studies to confirm the efficacy and safety of CD137-based therapies. Nonetheless, the future of the CD137 protein market in the US looks bright, with continued breakthroughs in immuno-oncology poised to drive substantial growth.
Additionally, the increasing integration of advanced technologies like 100 Gigabit Fiber Optic Transceivers in research facilities is helping accelerate the development of these therapies. Faster data transfer speeds are essential for handling the vast amounts of genomic and clinical data generated during clinical trials, allowing for quicker results and more efficient research.
Get an In-Depth Research Analysis of the Global CD137 Protein Market Size And Forecast [2025-2032]
Sino Biological
Inc.
Thermo Fisher
​​Abcam
Bio-Techne
G&P Biosciences
Abbexa
BPS Bioscience
Inc.
GeneTex
ZellBio GmbH
Elabscience Biotechnology Inc.
Bioworld Technology
Inc.
Boston Cellron
Boster Biological Technology
OriGene Technologies
Inc.
Innovative Research
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global CD137 Protein Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global CD137 Protein Market
Immunotherapy
Autoimmune Disorders
Cancer Treatment
Infectious Diseases
Vaccine Development
Pharmaceutical Companies
Biotechnology Firms
Research Institutions
Hospitals and Clinics
Academic and Educational Institutions
Recombinant CD137 Proteins
Monoclonal Antibodies
CD137 Agonists
CD137 Antagonists
CD137 Pathway Modulators
Direct Sales
Online Platforms
Distributors/Third-Party Vendors
Retail Pharmacies
Hospital Pharmacies
Native Protein Sources
Synthetic Production Techniques
Bioreactor Technologies
Cell Culture Systems
Recombinant DNA Technology
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ CD137 Protein Market Research Analysis
1. Introduction of the Global CD137 Protein Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global CD137 Protein Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global CD137 Protein Market, By Type
6. Global CD137 Protein Market, By Application
7. Global CD137 Protein Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global CD137 Protein Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/